Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:11 pm Sale |
2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
Point72 Asset Management, L.P. | 368,006 0.700% |
-2,052,303 (-84.80%) |
Filing History |
| 2023-02-14 10:04 am Purchase |
2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
RTW Investments, LP | 3,591,986 7.300% |
992,164 (+38.16%) |
Filing History |
| 2023-02-13 6:19 pm Sale |
2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
BIOTECHNOLOGY VALUE FUND L P | 1,250,000 2.500% |
-3,641,945 (-74.45%) |
Filing History |
| 2023-02-09 4:54 pm Purchase |
2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
FARALLON CAPITAL PARTNERS LP | 5,055,102 9.990% |
5,055,102 (New Position) |
Filing History |
| 2023-02-09 11:30 am Purchase |
2022-12-30 | 13G | Protagonist Therapeutics, Inc. PTGX |
The Vanguard Group | 3,097,714 6.300% |
3,097,714 (New Position) |
Filing History |
| 2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
BLACKROCK INC BLK |
3,652,157 7.400% |
370,521 (+11.29%) |
Filing History |
| 2023-01-11 1:00 pm Unchanged |
2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
JOHNSON & JOHNSON JNJ |
2,449,183 4.980% |
0 (Unchanged) |
Filing History |
| 2023-01-10 08:18 am Sale |
2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
STATE STREET CORP STT |
3,792,926 7.710% |
-2,983,343 (-44.03%) |
Filing History |
| 2023-01-03 4:22 pm Purchase |
2022-12-21 | 13G | Protagonist Therapeutics, Inc. PTGX |
Citadel Advisors LLC | 2,682,814 5.500% |
2,682,814 (New Position) |
Filing History |
| 2022-12-12 08:41 am Sale |
2022-12-09 | 13G | Protagonist Therapeutics, Inc. PTGX |
FMR CORP | 385,863 0.784% |
-3,168,232 (-89.14%) |
Filing History |
| 2022-07-11 11:51 am Purchase |
2022-06-30 | 13G | Protagonist Therapeutics, Inc. PTGX |
STATE STREET CORP STT |
6,776,269 13.930% |
4,204,699 (+163.51%) |
Filing History |
| 2022-06-10 11:04 am Sale |
2022-06-09 | 13G | Protagonist Therapeutics, Inc. PTGX |
FMR CORP | 3,554,095 7.304% |
-3,293,182 (-48.09%) |
Filing History |
| 2022-02-14 4:34 pm Sale |
2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
Point72 Asset Management, L.P. | 2,420,309 5.100% |
-1,908,721 (-44.09%) |
Filing History |
| 2022-02-14 1:57 pm Sale |
2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
Consonance Capital Management LP | 0 0.000% |
-2,729,709 (Position Closed) |
Filing History |
| 2022-02-14 08:07 am Sale |
2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
RTW Investments, LP | 2,599,822 5.400% |
-1,050,247 (-28.77%) |
Filing History |
| 2022-02-11 9:03 pm Purchase |
2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
BIOTECHNOLOGY VALUE FUND L P | 4,891,945 9.990% |
616,980 (+14.43%) |
Filing History |
| 2022-02-11 4:18 pm Sale |
2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
FARALLON CAPITAL MANAGEMENT LLC | 3,417,134 6.900% |
-507,866 (-12.94%) |
Filing History |
| 2022-02-10 3:41 pm Purchase |
2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
STATE STREET CORP STT |
2,571,570 5.390% |
2,571,570 (New Position) |
Filing History |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | Protagonist Therapeutics, Inc. PTGX |
FMR CORP | 6,847,277 14.346% |
394,513 (+6.11%) |
Filing History |
| 2022-02-02 7:11 pm Purchase |
2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
BLACKROCK INC BLK |
3,281,636 6.900% |
689,925 (+26.62%) |
Filing History |